We are happy to announce that Archimica is now CEP (Certification of Suitability) certified by the EDQM (European Directorate for the Quality of Medicines & HealthCare) for our API product, Mianserin.
The CEP certification confirms that our Mianserin is produced according to the EP monograph and meets the requirements of EU medicine directives.
At Archimica, we strive to maintain high standards in pharmaceutical manufacturing and development and aim to provide high-quality products and solutions to a wide range of audiences.
